Review





Similar Products

h post glucose loading plasma sparc  (R&D Systems)
90
R&D Systems h post glucose loading plasma sparc
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
H Post Glucose Loading Plasma Sparc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/Human+SPARC+DuoSet+ELISA/pmc13124276-203-9-22
Average 90 stars, based on 1 article reviews
h post glucose loading plasma sparc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
h 1500 10 sabouraud dextrose agar sda ward s  (Vector Laboratories)
96
Vector Laboratories h 1500 10 sabouraud dextrose agar sda ward s
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
H 1500 10 Sabouraud Dextrose Agar Sda Ward S, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/VECTASHIELD+Hardset+Antifade+Mounting+Medium+with+DAPI/pm41719138-101-59-56
Average 96 stars, based on 1 article reviews
h 1500 10 sabouraud dextrose agar sda ward s - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
freestyle libre h continuous glucose monitoring system  (Abbott Laboratories)
86
Abbott Laboratories freestyle libre h continuous glucose monitoring system
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
Freestyle Libre H Continuous Glucose Monitoring System, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/freestyle+libre+%D0%B4%D0%BB%D1%8F+%D0%B8%D1%81%D0%BF%D0%BE%D0%BB%D1%8C%D0%B7%D0%BE%D0%B2%D0%B0%D0%BB%D0%B8+%D1%81%D0%B8%D1%81%D1%82%D0%B5%D0%BC%D1%83+%D1%87%D0%B5%D0%B3%D0%BE/pm41416755-37-16-23
Average 86 stars, based on 1 article reviews
freestyle libre h continuous glucose monitoring system - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
h 2 deoxy d glucose 2 dg  (Moravek Biochemicals)
86
Moravek Biochemicals h 2 deoxy d glucose 2 dg
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
H 2 Deoxy D Glucose 2 Dg, supplied by Moravek Biochemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/1+2+2+2+3h+d+deoxy+dg+glucose/pmc12827289-486-10-12
Average 86 stars, based on 1 article reviews
h 2 deoxy d glucose 2 dg - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
freestyle optium neo h glucose meter  (Abbott Laboratories)
86
Abbott Laboratories freestyle optium neo h glucose meter
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
Freestyle Optium Neo H Glucose Meter, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/freestyle+glucometer+lite/pm41143542-1580-10-16
Average 86 stars, based on 1 article reviews
freestyle optium neo h glucose meter - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
h glucose tauc  (Randox)
97
Randox h glucose tauc
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
H Glucose Tauc, supplied by Randox, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/GLUCOSE/pmc12677009-5-80-115
Average 97 stars, based on 1 article reviews
h glucose tauc - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
dmem h high glucose medium  (Thermo Fisher)
99
Thermo Fisher dmem h high glucose medium
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
Dmem H High Glucose Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/D(%2B)-Glucose/pm41204452-54-22-25
Average 99 stars, based on 1 article reviews
dmem h high glucose medium - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
h glucose  (Amersham Life Sciences Inc)
86
Amersham Life Sciences Inc h glucose
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
H Glucose, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/3h+6+d+glucosamine/pmc12466289-98-9-13
Average 86 stars, based on 1 article reviews
h glucose - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
nadp h levels  (Thermo Fisher)
96
Thermo Fisher nadp h levels
Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h <t>and</t> <t>2-h</t> stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.
Nadp H Levels, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h+glucose/Glucose-6-phosphate+dehydrogenase/pm41096224-95-2-21
Average 96 stars, based on 1 article reviews
nadp h levels - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h and 2-h stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.

Journal: Life Metabolism

Article Title: Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

doi: 10.1093/lifemeta/loaf039

Figure Lengend Snippet: Change patterns of SPARC levels during OGTT at baseline, 3 months, and 6 months. (a–c) Plasma SPARC levels are increased after 1-h and 2-h stimulation of oral glucose intake in the three groups at baseline (a), while showing increasing trends at 3 months (b) and 6 months (c). Comparations were calculated by repeated-measures ANOVA, adjusting for sex, baseline age, baseline BMI, total energy intake, physical activity, smoking, and drinking. Post hoc pairwise comparisons between 0 h and 1 or 2 h were conducted with Bonferroni adjustment. For SPARC at baseline, n = 81 for the MD group, n = 81 for the TJD group, and n = 73 for the CD group. For SPARC at 3 months, n = 72 for the MD group, n = 73 for the TJD group, and n = 65 for the CD group. For SPARC at 6 months, n = 66 for the MD group, n = 61 for the TJD group, and n = 57 for the CD group.

Article Snippet: At baseline and follow-ups, fasting plasma SPARC, 1-h and 2-h post-glucose loading plasma SPARC were assessed by using the ELISA kits (DY941-05, R&D Systems) [ ].

Techniques: Clinical Proteomics, Activity Assay